Il Dong Pharmaceutical Co Ltd (249420) — Long-term Investment Intensity
Il Dong Pharmaceutical Co Ltd (249420) has a Long-term Investment Intensity of 1.9% as of December 2019. Long-term investments of ₩11.58 Billion represent 1.9% of total assets of ₩612.72 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See Il Dong Pharmaceutical Co Ltd shareholders equity for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Il Dong Pharmaceutical Co Ltd Long-term Investment Intensity (2016–2019)
This chart shows how Il Dong Pharmaceutical Co Ltd's Long-term Investment Intensity has evolved across 4 annual periods from 2016 to 2019. As of December 2019, the intensity stands at 1.9%, reflecting long-term investments of ₩11.58 Billion against total assets of ₩612.72 Billion KRW. Also explore 249420 asset base for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for Il Dong Pharmaceutical Co Ltd (2016–2019)
The table below presents the year-by-year Long-term Investment Intensity for Il Dong Pharmaceutical Co Ltd from 2016 to 2019, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Il Dong Pharmaceutical Co Ltd market capitalisation.
| Year | LT Investment Intensity | LT Investments (KRW) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2019 | 1.9% | ₩11.58 Billion | ₩612.72 Billion | ▲ +0.1 pp |
| 2018 | 1.8% | ₩9.97 Billion | ₩564.67 Billion | ▲ +0.0 pp |
| 2017 | 1.8% | ₩9.92 Billion | ₩564.63 Billion | ▲ +1.7 pp |
| 2016 | 0.0% | ₩144.50 Million | ₩550.35 Billion | — |